Search results
Apr 25, 2024 · Additional search capabilities provided in POCA include the United States Adopted Names (USAN) Council stem search algorithm and the non-proprietary name biologic suffix search tool. The...
May 3, 2024 · National Drug Code Directory free lookup service. Search by NDC code, product name, package codes, 11-digit NDC, active ingredients, RxCUI, dosage, and more.
People also ask
What is a proprietary name for a drug?
Why do drugs have a nonproprietary name?
What information is available for drug products approved since 1998?
What is Drugs@FDA?
May 3, 2024 · PROPRIETARY NAME: Humira: The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes. NON PROPRIETARY NAME: Adalimumab: The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product. DOSAGE FORM ...
- BLA125057
- BLA
- AbbVie Inc.
- HUMAN PRESCRIPTION DRUG
Apr 30, 2024 · International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name.
- Wade Lee-Smith
- 2010
May 13, 2024 · Drug Information (from Medlineplus.gov) -- Information about thousands of prescription and over-the-counter drugs, herbs, and supplements, collected from the American Society of Health-System Pharmacists (ASHP) and the United States Pharmacopeia (USP).
Apr 23, 2024 · Proprietary Name: DILTIAZEM HYDROCHLORIDE: Also known as the trade name. It is the name of the product chosen by the labeler. Non Proprietary Name: DILTIAZEM HYDROCHLORIDE: Sometimes called the generic name, this is usually the active ingredient(s) of the product. Substance Name: DILTIAZEM HYDROCHLORIDE: This is the active ingredient list.
May 13, 2024 · The high costs of brand-name prescription drugs that individuals in the US face have been a pressing concern for policymakers and patients. 1,2 In the US, manufacturers of brand-name drugs set high prices during periods of market exclusivity that can last 12 to 14 years or longer based on the patents covering the drug. 3 After exclusivity ...